The upcoming interim
analysis represents a key inflection point in our development program, which has already opened up
substantial opportunities for partnership discussions and licensing agreements both locally and
globally.”
'opened up substantial opportunities' is interesting phrasing - think this is more than a 'claytons' opportunity
just my opinion
- Forums
- ASX - By Stock
- AVE
- Ann: December 2024 Quarterly Activities Report & Appendix 4C
AVE
avecho biotechnology limited
Add to My Watchlist
0.00%
!
0.4¢

Ann: December 2024 Quarterly Activities Report & Appendix 4C, page-15
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.69M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $19.74K | 4.935M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 3510852 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 32271696 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 3510852 | 0.004 |
33 | 22444255 | 0.003 |
15 | 12700200 | 0.002 |
15 | 57221222 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 32271696 | 26 |
0.006 | 31623747 | 5 |
0.007 | 4498187 | 12 |
0.008 | 4597500 | 5 |
0.009 | 560000 | 2 |
Last trade - 15.15pm 26/06/2025 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online